Gaucher Disease Trial, Recruiting (NCT00358943)

Gaucher Disease Trial, Recruiting NCT00358943 Sponsor: Genzyme, a Sanofi Company Condition: Gaucher Disease

Printed from Voxsanity (voxsanity.com.au) — NCT00358943 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gaucher Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

For the main Gaucher Registry:

You have been confirmed to have Gaucher disease, proven either by a blood test showing low levels of a specific enzyme (called β-glucocerebrosidase) or by a genetic test showing a change in the related gene
You have given the appropriate permission/authorization to have your information included

For the Pregnancy Sub-registry (in addition to the above):

You are already enrolled in the main Gaucher Registry
You are currently pregnant, or you have been pregnant in the past and there are medical records available to document this
You have signed a consent form agreeing to take part in the Sub-registry before any of your information is collected

Who may not be able to join:

There are no exclusion criteria listed for either the main Registry or the Pregnancy Sub-registry — meaning there are no stated reasons that would automatically prevent someone from participating

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Study Director, Genzyme, a Sanofi Company

Phone: 800-633-1610

Australian sites

Investigational Site Number : 151431, Sydney, New South Wales

Investigational Site Number : 151069, Westmead, New South Wales

Investigational Site Number : 151010, Brisbane, Queensland

Investigational Site Number : 151491, Townsville, Queensland

Investigational Site Number : 151002, Adelaide, South Australia

Investigational Site Number : 151725, Hobart, Tasmania

Investigational Site Number : 151011, Clayton, Victoria

Investigational Site Number : 151008, Parkville, Victoria

Investigational Site Number : 151015, Murdoch, Western Australia

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00358943

Sponsor: Genzyme, a Sanofi Company

Phase: Not Applicable

Status: Recruiting

Condition: Gaucher Disease

Trial contact: 800-633-1610

More information: https://clinicaltrials.gov/study/NCT00358943

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

For the main Gaucher Registry:

You have been confirmed to have Gaucher disease, proven either by a blood test showing low levels of a specific enzyme (called β-glucocerebrosidase) or by a genetic test showing a change in the related gene
You have given the appropriate permission/authorization to have your information included

For the Pregnancy Sub-registry (in addition to the above):

You are already enrolled in the main Gaucher Registry
You are currently pregnant, or you have been pregnant in the past and there are medical records available to document this
You have signed a consent form agreeing to take part in the Sub-registry before any of your information is collected

Who may not be able to join:

There are no exclusion criteria listed for either the main Registry or the Pregnancy Sub-registry — meaning there are no stated reasons that would automatically prevent someone from participating

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Genzyme, a Sanofi Company

Registry

ClinicalTrials.gov

Start date

1 April 1991

Est. completion

31 January 2034

Where this trial is recruiting

🇦🇷 Argentina 🇦🇺 Australia 🇧🇪 Belgium 🇧🇷 Brazil 🇧🇬 Bulgaria 🇨🇦 Canada 🇨🇳 China 🇨🇴 Colombia 🇭🇷 Croatia 🇨🇿 Czechia 🇩🇰 Denmark Dominican Republic 🇪🇬 Egypt 🇫🇷 France 🇩🇪 Germany 🇬🇷 Greece Hong Kong 🇭🇺 Hungary 🇮🇳 India 🇮🇩 Indonesia 🇮🇱 Israel 🇮🇹 Italy 🇯🇵 Japan 🇯🇴 Jordan Kuwait 🇱🇧 Lebanon 🇱🇹 Lithuania 🇲🇾 Malaysia 🇳🇱 Netherlands 🇵🇰 Pakistan 🇵🇪 Peru 🇵🇭 Philippines 🇵🇱 Poland 🇵🇹 Portugal 🇷🇴 Romania 🇷🇺 Russia 🇸🇦 Saudi Arabia 🇷🇸 Serbia 🇸🇬 Singapore 🇸🇰 Slovakia 🇿🇦 South Africa 🇰🇷 South Korea 🇪🇸 Spain 🇸🇪 Sweden 🇨🇭 Switzerland 🇹🇼 Taiwan 🇹🇭 Thailand Turkey (Türkiye) 🇦🇪 United Arab Emirates 🇬🇧 United Kingdom 🇺🇸 United States 🇻🇳 Vietnam

9 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

ICGG Gaucher Registry: To provide the Gaucher medical community with recommendations for monitoring patients and to provide reports on patient outcomes to help optimize patient care; Gaucher Pregnancy Sub-registry: To track pregnancy outcomes, including complications and infant growth, in all women with Gaucher disease during pregnancy, regardless of whether they receive disease-specific therapy, such as ERT with imiglucerase

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov